Latest Journal Headlines:
[What is this?]
|
| Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of gp120. FASEB Journal. (Posted: January 31, 2003) |
| Minireview — Latency in human immunodeficiency virus type 1 infection: No easy answers. Journal of Virology. (Posted: January 31, 2003) |
| Changes in the immunogenicity of soluble gp140 constructs upon deletion of the V2 loop. Journal of Virology. (Posted: January 31, 2003) |
| Mucosal priming of SIV-specific CTL in macaques by the Salmonella type III secretion system. Journal of Virology. (Posted: January 31, 2003) |
| Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation. AIDS. (Posted: January 30, 2003) |
| CD4-dependent and CD4-independent HIV-2: consequences for neutralization. AIDS. (Posted: January 30, 2003) |
| Post-exposure prophylaxis with human mAbs prevented SHIV89.6P infection/disease in neonatal macaques. AIDS. (Posted: January 30, 2003) |
| Safety and tolerability of vaginal PRO 2000 gel, a naphthalene sulfonate polymer microbicide. AIDS. (Posted: January 30, 2003) |
| Effects of CCR5-D32 and CCR2-64I alleles on HIV-1 disease progression. AIDS. (Posted: January 30, 2003) |
| Current HIV/AIDS-related knowledge, attitudes, and practices in China: Implications for action. AIDScience. (Posted: January 28, 2003) |
| Latency in human immunodeficiency virus type 1 infection: No easy answers. Journal of Virology. (Posted: January 26, 2003) |
| A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag. Journal of Immunology. (Posted: January 23, 2003) |
| NeuroAIDS: Induction of apoptosis by HIV-1-infected monocytic cells. Journal of Immunology. (Posted: January 23, 2003) |
| Peripheral blood CTLs from patients with HIV-1 infection and AIDS lyse uninfected CD4+ T cells. Journal of Virology. (Posted: January 22, 2003) |
| Human HIV-1 Nef-mediated downregulation of CD4 correlates with Nef enhancement of viral pathogenesis. Journal of Virology. (Posted: January 22, 2003) |
| Effect of humoral immune responses on viremia during primary infection of rhesus monkeys with SIV. Journal of Virology. (Posted: January 22, 2003) |
| Amplification of a complete SIV genome from fecal RNA of a wild chimpanzee. Journal of Virology. (Posted: January 22, 2003) |
| Noninvasive detection of new simian immunodeficiency virus lineages in captive sooty mangabeys. Journal of Virology. (Posted: January 22, 2003) |
| Peptides trap the hHIV-1 envelope glycoprotein fusion intermediate at two sites. Journal of Virology. (Posted: January 22, 2003) |
| Enhancement of antibodies to the HIV-1 envelope by using the molecular adjuvant C3d. Journal of Virology. (Posted: January 22, 2003) |
| The effect of rapid HIV-1 testing on uptake of perinatal HIV-1 interventions. AIDS. (Posted: January 16, 2003) |
| Scaling HIV vaccine attitudes among gay men in Sydney, Australia. AIDS Research and Human Retroviruses. (Posted: January 16, 2003) |
| Phase I trial of a therapeutic HIV type 1 vaccine, Vacc-4x, in HIV type 1-infected individuals. AIDS Research and Human Retroviruses. (Posted: January 16, 2003) |
| Suppression of chemokine receptor expression by RNA interference. AIDS. (Posted: January 15, 2003) |
| Effect of promoters on CTL response induced by recombinant fowlpox virus expressing MEP. Biotechnology and Applied Biochemistry. (Posted: January 13, 2003) |
| Is HIV superinfection worrisome?. Lancet. (Posted: January 13, 2003) |
| NeuroAIDS: Functional CXCR4 receptor development parallels sensitivity to HIV-1 gp120. Journal of Neurovirology. (Posted: January 13, 2003) |
| NeuroAIDS: Neurovirulence depends on virus input titer in brain in feline immunodeficiency virus infection. Journal of Neurovirology. (Posted: January 13, 2003) |
| HIV-1 Nef downregulates MHC-I by a PACS-1-and PI3K-regulated ARF6 endocytic pathway. Cell. (Posted: January 13, 2003) |
| Routine utilization of zidovudine to reduce mother-to-child transmission of HIV-1 in West Africa. AIDS. (Posted: January 13, 2003) |
| Increase in at-risk sexual behaviour among HIV-1-infected patients. AIDS. (Posted: January 13, 2003) |
| Estimating the effectiveness and efficiency of U.S. HIV prevention efforts. AIDS. (Posted: January 13, 2003) |
| Are HIV drug advertisements contributing to increases in risk behavior among men?. AIDS. (Posted: January 13, 2003) |
| SHIV-KB9 infection of rhesus monkeys does not always cause disease. Virology. (Posted: January 13, 2003) |
| Replication of HIV-1 deleted Nef mutants in chronically immune activated human T cells. Virology. (Posted: January 13, 2003) |
| Construction and in vitro properties of chimeric SHIV with the human TNF-alpha gene. Microbiology and Immunology. (Posted: January 13, 2003) |
| Human immunodeficiency virus type 1 neutralization by a single molecule of V3-targeted antibody. Microbiology and Immunology. (Posted: January 13, 2003) |
| NeuroAIDS: HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium. Journal of Neurochemistry. (Posted: January 13, 2003) |
| HSV-2 infection as a risk factor for HIV acquisition in men who have sex with men. The Journal of Infectious Diseases. (Posted: January 13, 2003) |
| Opportunity for prevention of HIV and sexually transmitted infections in Kenyan youth. Journal of Acquired Immune Deficiency Syndromes. (Posted: January 13, 2003) |
| Synthetic AIDS vaccine by targeting HIV receptor. Vaccine. (Posted: January 13, 2003) |
| Lack of toxicity and persistence in the mouse of candidate DNA- and MVA-based HIV vaccines. Vaccine. (Posted: January 13, 2003) |
| NeuroAIDS: Medication adherence among HIV+ adults - Effects of cognitive dysfunction and regimen complexity. Neurology. (Posted: January 13, 2003) |
| HIV testing within at-risk populations in the United States. Journal of Acquired Immune Deficiency Syndromes. (Posted: January 13, 2003) |
| HIV mucosal vaccine: nasal immunization with gp160-HVJ-liposome induces CTLs and neutralizing Abs. Journal of Immunology. (Posted: January 12, 2003) |
| Travel and the spread of HIV-1 genetic variants. Lancet Infectious Diseases. (Posted: January 9, 2003) |
| A truncated form of Nef selected during pathogenic reversion increases viral replication. Journal of Virology. (Posted: January 9, 2003) |
| HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. (Posted: January 9, 2003) |
| Course and outcome of pregnancy in 54 persistently HIV-1-seronegative sex workers and their infants. Journal of Reproductive Medicine. (Posted: January 8, 2003) |
| Comparing the ex vivo fitness of CCR5-tropic HIV-1 isolates of subtypes B and C. Journal of Virology. (Posted: January 6, 2003) |
| Two HIV vaccinal lipopeptides follow different cross-presentation pathways in human dendritic cells. Journal of Virology. (Posted: January 6, 2003) |
| Prevention of disease induced by a partially heterologous AIDS virus in Rhesus monkeys. Journal of Virology. (Posted: January 6, 2003) |
| Control of viremia and prevention of SHIV-induced disease in immunized Rhesus macaques. Journal of Virology. (Posted: January 6, 2003) |
| Association between virus-specific T-cell responses and plasma viral load in HIV-1 C infection. Journal of Virology. (Posted: January 6, 2003) |
| Increased mucosal transmission but not enhanced pathogenicity of SHIV SF162P3 maps to envelope gp120. Journal of Virology. (Posted: January 6, 2003) |
| Immunization with SIV vaccines prolongs survival after oral challenge with virulent SIVmac251. Journal of Virology. (Posted: January 3, 2003) |
| NeuroAIDS: Role of microglial cells in selective replication of SIV genotypes in the brain. Journal of Virology. (Posted: January 3, 2003) |
| Ontogeny and specificities of mucosal and blood HIV-1-specific CD8+ cytotoxic T lymphocytes. Journal of Virology. (Posted: January 3, 2003) |
| Importance of B-cell responses for immunological control of variant strains of SIV. Journal of Virology. (Posted: January 3, 2003) |
| CD4 binding site antibodies inhibit HIV gp120 envelope glycoprotein interaction with CCR5. Journal of Virology. (Posted: January 2, 2003) |
| Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with gp120. Journal of Virology. (Posted: January 2, 2003) |
| A potential gp41 binding site in gp120 and mechanisms of primary virus neutralization resistance. Journal of Virology. (Posted: January 2, 2003) |
| Heterogeneity of envelope molecules expressed on primary HIV-1 particles. Journal of Virology. (Posted: January 2, 2003) |
| Primary HIV-1 infection in African children infected through breastfeeding. AIDS. (Posted: January 1, 2003) |
| The epidemiological and control implications of HIV transmission probabilities within partnerships. Sexually Transmitted Diseases. (Posted: December 30, 2002) |
| NeuroAIDS: Searching for clues: Tracking the pathogenesis of HIV central nervous system disease. The Journal of Infectious Diseases. (Posted: December 30, 2002) |
| Rapid induction of apoptosis in CD8(+) HIV-1 envelope-specific murine CTLs. Journal of Immunology. (Posted: December 30, 2002) |
| Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection. Proc. Natl. Acad. Sci. USA. (Posted: December 30, 2002) |
| HIV Nef inhibits T cell migration. Journal of Biological Chemistry. (Posted: December 30, 2002) |
| Why are CD4(+) but not CD8(+) T cells depleted?. Proc. Natl. Acad. Sci. USA. (Posted: December 30, 2002) |
| Implications for vaccine design of peptide structural conformation. Journal of Biological Chemistry. (Posted: December 30, 2002) |
| Haemophilus ducreyi infection and its relevance to HIV-1 acquisition. Journal of Immunology. (Posted: December 30, 2002) |
| Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial. Journal of Acquired Immune Deficiency Syndromes. (Posted: December 26, 2002) |
| Inactivation of human immunodeficiency virus type 1 by porphyrins. Antimicrobial Agents and Chemotherapy. (Posted: December 26, 2002) |
| Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA. Proc. Natl. Acad. Sci. USA. (Posted: December 24, 2002) |
| Therapeutic dendritic-cell vaccine for simian AIDS. Nature Medicine. (Posted: December 24, 2002) |
| Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors. Clinical and Experimental Immunology. (Posted: December 17, 2002) |
| Short-course therapy with zidovudine plus lamivudine for prevention of mother-to-child transmission. Clinical Infectious Diseases. (Posted: December 17, 2002) |
| NeuroAIDS: A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment. Neurology. (Posted: December 17, 2002) |
| HIV-1 evades antibody-mediated neutralization. Nature. (Posted: December 17, 2002) |
| HIV prevalence among foreign- and US-born clients of public STD clinics. American Journal of Public Health. (Posted: December 17, 2002) |
| NeuroAIDS: Up-regulation of MAP2e-expressing oligodendrocytes in the white matter in HIV-1 encephalitis. Neuropathology and Aplied Neurobiology. (Posted: December 17, 2002) |
| NeuroAIDS: Neurotoxic effects of Tat require function of a polyamine sensitive-site on the NMDAr. Brain Research. (Posted: December 17, 2002) |
| Recombinant multi-epitope vaccine induced predefined epitope-specific antibodies against HIV-1. Immunology Letters. (Posted: December 17, 2002) |
| NeuroAIDS: Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology. (Posted: December 17, 2002) |
| Allocating HIV-prevention resources: Balancing efficiency and equity. American Journal of Public Health. (Posted: December 17, 2002) |
| Screening for HIV infection in high-risk communities by urine antibody testing. Journal of Acquired Immune Deficiency Syndromes. (Posted: December 17, 2002) |
| NeuroAIDS: Neuroanatomical distribution of CXCR4 in adult rat brain. European Journal of Neuroscience. (Posted: December 11, 2002) |
| A 13-week subchronic intravaginal toxicity study of the novel anti-HIV and spermicidal agent PHI-346. Toxicologic Pathology. (Posted: December 11, 2002) |
| Restricted replication of primary HIV-1 isolates using both CCR5 and CXCR4 in Th2. Journal of Leukocyte Biology. (Posted: December 11, 2002) |
| Subcompartmentalization of HIV-1 quasispecies in distinct genital tissues. AIDS Research and Human Retroviruses. (Posted: December 11, 2002) |
| Blood banking in China. Lancet. (Posted: December 11, 2002) |
| Multiple determinants are involved in HIV coreceptor use. Journal of Leukocyte Biology. (Posted: December 11, 2002) |
| Prevention of HIV-1 infection in human PBMCs by specific RNA interference. Nucleic Acids Research. (Posted: December 11, 2002) |
| HIV-1 subtype C exhibits higher transactivation activity of Tat than subtypes B and E. Microbiology and Immunology. (Posted: December 11, 2002) |
| Double-stranded nef RNA interferes with human immunodeficiency virus type 1 replication. Microbiology and Immunology. (Posted: December 11, 2002) |
| NeuroAIDS: Mechanisms of HIV type 1-induced cognitive impairment. AIDS Research and Human Retroviruses. (Posted: December 8, 2002) |
| A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nature Biotechnology. (Posted: December 8, 2002) |
| Elevated levels of circulating interleukin-18 in HIV-infected individuals. Journal of Virology. (Posted: December 8, 2002) |
| HIV-1-specific CD8+-T-cell responses for groups of individuals with different HLA-B*35 genotypes. Journal of Virology. (Posted: December 8, 2002) |
| Neutralizing antibody induced in mice by novel glycoconjugates of HIV-1 gp120 and env2-3. The Journal of Infectious Diseases. (Posted: December 8, 2002) |
| Interleukin-18 enhances HIV-1 production in a human chronically-infected T cell line (H9-V). Cell Biochemistry and Function. (Posted: December 8, 2002) |
| Short constrained peptides that inhibit HIV-1 entry. Proc. Natl. Acad. Sci. USA. (Posted: December 8, 2002) |
| Vaccination with apoptotic HIV-1/murine leukemia virus-infected cells. Journal of Immunology. (Posted: December 8, 2002) |
| NeuroAIDS: Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology. (Posted: December 8, 2002) |
| Mamu-A*01 allele-mediated attenuation of disease progression in SHIV infection. Journal of Virology. (Posted: December 8, 2002) |
| RNA interference directed against viral and cellular targets inhibits HIV-1 replication. Journal of Virology. (Posted: December 8, 2002) |
| Use of SAMMA, a new antimicrobial contraceptive agent, for vaginal prophylaxis. Fertility and Sterility. (Posted: December 5, 2002) |
| Inverse correlation between memory gag-specific CTLs and viral replication. The Journal of Infectious Diseases. (Posted: December 4, 2002) |
| Human antibodies, epitope exposure, binding and neutralization of primary isolate HIV-1 virions. AIDS. (Posted: December 4, 2002) |
| T-cell responses in normal volunteers immunized with a DNA-based vaccine containing env and rev. AIDS. (Posted: December 4, 2002) |
| Impact of sexually transmitted disease treatment on HIV transmission. AIDS. (Posted: December 4, 2002) |
| Correlation between breadth of memory HIV-specific CTLs, viral load and disease progression. AIDS. (Posted: December 4, 2002) |
| Risk of HIV infection attributable to oral sex among men who have sex with men. AIDS. (Posted: December 4, 2002) |
| Novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades. AIDS. (Posted: December 3, 2002) |
| NeuroAIDS: HAD patients exhibit reduced viral neutralization and increased envelope sequence diversity. AIDS. (Posted: December 3, 2002) |
| NeuroAIDS: Pathological findings in the CNS of AIDS patients on assumed antiretroviral therapeutic regimens. AIDS. (Posted: December 3, 2002) |
| Prevention of perinatal HIV transmission. Drugs. (Posted: December 3, 2002) |
| NeuroAIDS: Supplement with reviews on neuroAIDS. Journal of Acquired Immune Deficiency Syndromes. (Posted: December 3, 2002) |
| Lack of Epstein-Barr virus- and HIV-specific CD27- CD8+ T cells is associated with progression. AIDS. (Posted: December 3, 2002) |
| NeuroAIDS: Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. Journal of Neurochemistry. (Posted: December 3, 2002) |
| HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature. (Posted: November 28, 2002) |
| NeuroAIDS: Relationships among brain metabolites, cognitive function, and viral loads. Neuroimage. (Posted: November 25, 2002) |
| NeuroAIDS: Microglia in human immunodeficiency virus-associated neurodegeneration. Glia. (Posted: November 25, 2002) |
| A nucleolar TAR decoy inhibitor of HIV-1 replication. Proc. Natl. Acad. Sci. USA. (Posted: November 25, 2002) |
| NeuroAIDS: HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons. J. Neuropathol. Exp. Neurol.. (Posted: November 25, 2002) |
| NeuroAIDS: Circulating gp120 alters the blood-brain barrier permeability in HIV-1 gp120 transgenic mice. Neuroscience Letters. (Posted: November 25, 2002) |
| Markers of HIV-1 disease progression in individuals with haemophilia coinfected with HCV. Lancet. (Posted: November 25, 2002) |
| Immune responses against SIV envelope glycoprotein, using a recombinant SV40 vector. Vaccine. (Posted: November 25, 2002) |
| NeuroAIDS: Acute meningoencephalitis and meningitis due to primary HIV infection. British Medical Journal. (Posted: November 22, 2002) |
| Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. Journal of Immunology. (Posted: November 18, 2002) |
| The burden of infectious disease among inmates of and releasees from US correctional facilities. American Journal of Public Health. (Posted: November 18, 2002) |
| NeuroAIDS: Feedback between glial tumor necrosis factor-alpha and gp120 from HIV-infected cells. Neuroimmunomodulation. (Posted: November 18, 2002) |
| Vaccination of macaques with long-standing SIVmac251 infection. Journal of Immunology. (Posted: November 18, 2002) |
| Containment of simian immunodeficiency virus infection in vaccinated macaques. Journal of Immunology. (Posted: November 18, 2002) |
| NeuroAIDS: HIV-related neuropathology, 1985 to 1999: Rising prevalence of HIV encephalopathy. Journal of Acquired Immune Deficiency Syndromes. (Posted: November 12, 2002) |
| Beyond Cr-51 release: new methods for assessing HIV-1-specific CD8(+) T cell responses. Clinical and Experimental Immunology. (Posted: November 12, 2002) |
| Amino acid deletions are introduced into the V2 region of gp120. Proc. Natl. Acad. Sci. USA. (Posted: November 12, 2002) |
| A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc. Natl. Acad. Sci. USA. (Posted: November 12, 2002) |
| Differences between T cell epitopes recognized after immunization and after infection. Journal of Immunology. (Posted: November 12, 2002) |
| NeuroAIDS: Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1. Brain Pathology. (Posted: November 12, 2002) |
| Capture and transfer of SIV by macaque dendritic cells is enhanced by DC-SIGN. Journal of Virology. (Posted: November 12, 2002) |
| Antigenic properties of the HIV transmembrane glycoprotein during cell-cell fusion. Journal of Virology. (Posted: November 12, 2002) |
| Virus population homogenization following acute human immunodeficiency virus type 1 infection. Journal of Virology. (Posted: November 12, 2002) |
| NeuroAIDS: Regulation of indoleamine 2,3-dioxygenase expression in SIV-infected monkey brains. Journal of Virology. (Posted: November 12, 2002) |
| HIV risk behaviors among African American men who self-identify as heterosexual. Journal of Acquired Immune Deficiency Syndromes. (Posted: November 12, 2002) |
| The HLA class II transcriptional activator blocks the function of HIV-1 Tat. European Journal of Immunology. (Posted: November 12, 2002) |
| A consensus sequence from prevalent and incident HIV-1 infections to guide AIDS vaccine development. Virology. (Posted: November 12, 2002) |
| Functional discrepancies in HIV-specific CD8(+)s are related to plasma virus load. Journal of Clinical Immunology. (Posted: November 12, 2002) |
| NeuroAIDS: HIV-related movement disorders: epidemiology, pathogenesis and management. CNS Drugs. (Posted: November 12, 2002) |
| NeuroAIDS: Reaction time slowing in adults with HIV: Results of a meta-analysis using brinley plots. Brain and Cognition. (Posted: November 12, 2002) |
| Transmission of HIV-1 through breastfeeding among women in Dar es Salaam, Tanzania. Journal of Acquired Immune Deficiency Syndromes. (Posted: November 12, 2002) |
| NeuroAIDS: IL-6 and cAMP induce stromal cell-derived factor-1 chemotaxis in astroglia by up-regulating CXCR4. Journal of Biological Chemistry. (Posted: November 12, 2002) |
| Efficacy of strategies to reduce mother-to-child HIV-1 transmission in Argentina, 1993-2000. Journal of Acquired Immune Deficiency Syndromes. (Posted: November 12, 2002) |
| NeuroAIDS: Characterization of an in vitro rhesus macaque blood-brain barrier. Journal of Neuroimmunology. (Posted: November 12, 2002) |
| NeuroAIDS: Human immunodeficiency virus type 1 (HIV-1) Tat induces nitric-oxide synthase in human astroglia. Journal of Biological Chemistry. (Posted: November 12, 2002) |
| Enhanced immune responses after DNA vaccination with combined different envelope genes. Virology. (Posted: November 12, 2002) |
| Two- to sixfold decreased odds of HIV risk behavior associated with use of SEPs. Journal of Acquired Immune Deficiency Syndromes. (Posted: November 7, 2002) |
| HIV infections in sub-Saharan Africa not explained by sexual or vertical transmission. International Journal of STD & AIDS. (Posted: November 6, 2002) |
| The functional CD8 T cell response to HIV becomes type-specific in progressive disease. Journal of Clinical Investigation. (Posted: November 6, 2002) |
| Precision and accuracy of a procedure for detecting recent HIV infections. Journal of Clinical Microbiology. (Posted: November 1, 2002) |
| Immune-mediated positive selection drives HIV-1 molecular variation and predicts disease duration. Journal of Virology. (Posted: October 31, 2002) |
| Mandelic acid condensation polymer: Novel candidate microbicide for prevention of HIV. Journal of Virology. (Posted: October 31, 2002) |
| Stable expression of primary HIV-1 structural gene products by a noncytopathic Sindbis virus vector. Journal of Virology. (Posted: October 31, 2002) |
| Elicitation of SIV-specific CTLs in mucosal compartments of rhesus monkeys by systemic vaccination. Journal of Virology. (Posted: October 31, 2002) |
| Escape in one of two CTL epitopes bound by a high-frequency MHC class I molecule, Mamu-A*02. Journal of Virology. (Posted: October 31, 2002) |
| Both mucosal and systemic routes of immunization result in mucosal Gag T-cell responses. Journal of Virology. (Posted: October 31, 2002) |
| Live, attenuated SIVmac-M4 provides partial protection from mucosal challenge. Journal of Virology. (Posted: October 31, 2002) |
| NeuroAIDS: HIV dementia patients exhibit reduced viral neutralization and increased envelope sequence diversity. AIDS. (Posted: October 31, 2002) |
| Association of Gag-specific T lymphocyte responses and lower virus load set point. The Journal of Infectious Diseases. (Posted: October 31, 2002) |
| HLA typing in a Kenyan cohort identifies novel class I alleles that restrict CTL responses. AIDS. (Posted: October 31, 2002) |
| Selected major risk factors and global and regional burden of disease. Lancet. (Posted: October 31, 2002) |
| Comparative study of immune responses induced after immunization with plasmids encoding Nef protein. Vaccine. (Posted: October 31, 2002) |
| Synergistic adjuvant activity of immunostimulatory DNA and oil/water emulsions. Vaccine. (Posted: October 31, 2002) |
| Development of HIV-1 Nef vaccine components. Vaccine. (Posted: October 31, 2002) |
| Rectal applications of nonoxynol-9 cause tissue disruption in a monkey model. Sexually Transmitted Diseases. (Posted: October 31, 2002) |
| Entry of inflammatory cells into the mouse vagina following application of candidate microbicides. Sexually Transmitted Diseases. (Posted: October 31, 2002) |
| Inactivation of HIV in blood. Transfusion. (Posted: October 31, 2002) |
| NeuroAIDS: Expression of EAAT-2 and GS in brain macrophages and microglia of SIVmac251-infected macaques. Neuropathology and Applied Neurobiology. (Posted: October 31, 2002) |
| Effects of different HIV strains on thymic epithelial cultures. Pathobiology. (Posted: October 31, 2002) |
| Tat HIV-1 primary and tertiary structures critical to immune response. Journal of Biological Chemistry. (Posted: October 31, 2002) |
| Salivary SLPI is associated with reduced transmission of HIV-1 through breast milk. The Journal of Infectious Diseases. (Posted: October 30, 2002) |
| Comprehensive health care for people infected with HIV in developing countries. British Medical Journal. (Posted: October 30, 2002) |
| Novel transgenic mouse/SCID-hu mouse to characterize in vivo behavior of reservoirs of HIV-1. The Journal of Infectious Diseases. (Posted: October 30, 2002) |
| Immunogenicity of HIV-1IIIB and SHIV 89.6P Tat and Tat toxoids in rhesus macaques. DNA and Cell Biology. (Posted: October 25, 2002) |
| Tat and Rev-targeted immunization as a preventive vaccine against mucosal challenge with SHIV-BX08. DNA and Cell Biology. (Posted: October 25, 2002) |
| Promising microbicide approach for prevention of HIV transmission needs more support. Pharmacotherapy. (Posted: October 25, 2002) |
| Vitamin supplements in relation to transmission of HIV-1 through breastfeeding. AIDS. (Posted: October 25, 2002) |
| A push-pull approach to maximize vaccine efficacy. Proc. Natl. Acad. Sci. USA. (Posted: October 25, 2002) |
| Breastmilk erythropoietin and mother-to-child HIV transmission through breastmilk. Lancet. (Posted: October 25, 2002) |
| Immunization of macaques with live SHIV vaccines conferred protection against AIDS. Virology. (Posted: October 25, 2002) |
| A SIV nef peptide is a dominant cytotoxic T lymphocyte epitope. Virology. (Posted: October 25, 2002) |
| Lymphoid activation: a confounding factor in AIDS vaccine development?. Journal of General Virology. (Posted: October 25, 2002) |
| In vivo priming of HIV-specific CTLs determines selective cross-reactive immune responses. Journal of Immunology. (Posted: October 25, 2002) |
| HIV-1 Tat-based vaccines: From basic science to clinical trials. DNA and Cell Biology. (Posted: October 25, 2002) |
| Targeting Tat and IFN alpha as a therapeutic AIDS vaccine. DNA and Cell Biology. (Posted: October 25, 2002) |
| Design and in vivo immunogenicity of a polyvalent vaccine based on SIVmac regulatory genes. DNA and Cell Biology. (Posted: October 25, 2002) |
| NeuroAIDS: HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele. Proc. Natl. Acad. Sci. USA. (Posted: October 24, 2002) |
| Characterization of sexually transmitted disease clinic patients with recent HIV infection. The Journal of Infectious Diseases. (Posted: October 22, 2002) |
| Prime-boost immunization with DNA and modified vaccinia virus ankara vectors. The Journal of Infectious Diseases. (Posted: October 21, 2002) |
| Mucosal immunization with inactivated HIV virus plus CpG oligodeoxynucleotides. The Journal of Infectious Diseases. (Posted: October 21, 2002) |
| Preparation of clinical-grade recombinant canarypox HIV vaccine loaded human dendritic cells. The Journal of Infectious Diseases. (Posted: October 21, 2002) |
| Heat-denatured HIV-1 protein 24 antigen: Prognostic value in adults with early-stage disease. The Journal of Infectious Diseases. (Posted: October 21, 2002) |
| Effects of CTLs directed against a single SIV Gag CTL epitope on the course of SIVmac239 infection. Journal of Virology. (Posted: October 18, 2002) |
| NeuroAIDS: Glucocorticoid exacerbation of gp120 neurotoxicity: Role of microglia. Experimental Neurology. (Posted: October 18, 2002) |
| Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization. Journal of Virology. (Posted: October 18, 2002) |
| Diversity of receptors binding HIV on dendritic cell subsets. Nature Immunology. (Posted: October 18, 2002) |
| Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes. European Journal of Immunology. (Posted: October 18, 2002) |
| Slowly declining levels of viral RNA and DNA in vaccinated macaques. Journal of Virology. (Posted: October 18, 2002) |
| Magnitude and frequency of CTL responses: identification of immunodominant regions. Journal of Virology. (Posted: October 18, 2002) |
| Are HIV care providers talking with patients about safer sex and disclosure?. AIDS. (Posted: October 15, 2002) |
| A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine. Vaccine. (Posted: October 11, 2002) |
| Vpr accessory gene in a plasmid vaccine cocktail markedly reduces Nef vaccine effectiveness. Journal of Medical Primatology. (Posted: October 11, 2002) |
| Characterization of CD4+T helper cell fine specificity to the envelope glycoproteins of SIH. Journal of Medical Primatology. (Posted: October 11, 2002) |
| Protection by SIVVLP DNA prime/protein boost following mucosal SIV challenge. Journal of Medical Primatology. (Posted: October 11, 2002) |
| NeuroAIDS: Magnetic resonance spectroscopy: an in vivo tool for monitoring cerebral injury in SIV. Journal of Medical Primatology. (Posted: October 11, 2002) |
| Preclinical AIDS vaccine research: survey of SIV, SHIV, and HIV challenge studies. Journal of Medical Primatology. (Posted: October 11, 2002) |
| T cell receptor usage in patients with non-progressing HIV infection. Clinical and Experimental Immunology. (Posted: October 11, 2002) |
| Immunologic profile of highly exposed yet HIV type 1-seronegative men. AIDS Research and Human Retroviruses. (Posted: October 11, 2002) |
| HIV-1 transcription and virus production are induced by MRPs in human CD4(+) T lymphocytes. Journal of Immunology. (Posted: October 11, 2002) |
| CD4 T cell depletion is linked directly to immune activation but only indirectly to the viral load. Journal of Immunology. (Posted: October 11, 2002) |
| MHC class I alleles influence set-point viral load and survival time in SIV-infected rhesus monkeys. Journal of Immunology. (Posted: October 11, 2002) |
| Cross-clade T lymphocyte-mediated immunity to HIV type 1. AIDS Research and Human Retroviruses. (Posted: October 11, 2002) |
| Rhesus macaques that resist repeated intravaginal challenge with SIVmac251. AIDS Research and Human Retroviruses. (Posted: October 11, 2002) |
| AIDS vaccines, immunology, and what we have learned. The AIDS Reader. (Posted: October 10, 2002) |
| Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999. Sexually Transmitted Infections. (Posted: October 10, 2002) |
| HIV-specific CD8+ T cell proliferation is maintained in nonprogressors. Nature Immunology. (Posted: October 8, 2002) |
| HIV-seropositive individuals' optimistic beliefs about prognosis. Journal of General Internal Medicine. (Posted: October 7, 2002) |
| Development of vaccination strategies that elicit broadly neutralizing antibodies against HIV-1. Journal of Human Virology. (Posted: October 7, 2002) |
| CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV. Journal of Immunology. (Posted: October 7, 2002) |
| Associations between MHC class I and susceptibility to HIV-2 disease progression. Journal of Human Virology. (Posted: October 7, 2002) |
| Temporal trends in the incidence of HIV infection and risk behavior among ID users. American Journal of Epidemiology. (Posted: October 4, 2002) |
| Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Natl. Acad. Sci. USA. (Posted: October 3, 2002) |
| NeuroAIDS: Persistent SIV infection of a blood-brain barrier model. Journal of Neurovirology. (Posted: October 3, 2002) |
| Fetal feline immunodeficiency virus is prevalent and occult. The Journal of Infectious Diseases. (Posted: October 3, 2002) |
| Determinants of mother-to-infant HIV-1 transmission before and after zidovudine prophylaxis. Archives of Pediatrics & Adolescent Medicine. (Posted: October 3, 2002) |
| NeuroAIDS: HIV-1-associated dementia: A basic science and clinical perspective. AIDS Reader. (Posted: October 2, 2002) |
| Serum IgA of HIV-exposed uninfected individuals inhibit HIV. AIDS. (Posted: October 1, 2002) |
| Multiple subtypes of HIV-1 and HIV-2 are sensitive to a chemokine-receptor CXCR4 antagonist. Journal of Medical Virology. (Posted: October 1, 2002) |
| Risk behaviors and HIV incidence among repeat testers. Journal of Acquired Immune Deficiency Syndromes. (Posted: September 30, 2002) |
| NeuroAIDS: Neuropathogenesis of lentiviral infection in macaques - Roles of CXCR4 and CCR5 viruses and IL-4. American Journal of Pathology. (Posted: September 29, 2002) |
| Functional neutralization of Vif by intracellular immunization inhibits RT and viral replication. Journal of Biological Chemistry. (Posted: September 29, 2002) |
| Contribution of human alpha-defensin-1, -2 and -3 to the anti-HIV-1 activity of CD8 antiviral factor. Science. (Posted: September 29, 2002) |
| Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other STIs. Lancet Infectious Diseases. (Posted: September 27, 2002) |
| Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission. Lancet. (Posted: September 27, 2002) |
| Diversity of receptors binding HIV on dendritic cell subsets. Nature Immunology. (Posted: September 24, 2002) |
| Characterization of sexually transmitted disease clinic patients with recent HIV infection. The Journal of Infectious Diseases. (Posted: September 23, 2002) |
| NeuroAIDS: Mixed lineage kinase 3 mediates gp120IIIB-induced neurotoxicity. Journal of Neurochemistry. (Posted: September 23, 2002) |
| Factors associated with HIV testing among HIV-positive and HIV-negative high-risk adolescents. Pediatrics. (Posted: September 23, 2002) |
| Blockade of HIV-1 infection of new world monkey cells occurs primarily at the stage of virus entry. Journal of Experimental Medicine. (Posted: September 23, 2002) |
| NeuroAIDS: HIV-I-induced production of endothelin-I in an in vitro model of the human blood-brain barrier. Neuroreport. (Posted: September 23, 2002) |
| Novel promiscuous HLA-DQ HIV Nef peptide that induces IFN-gamma-producing memory CD4(+) T cells. Clinical and Experimental Immunology. (Posted: September 23, 2002) |
| Allo-immunization elicits CCR5 antibodies that inhibit transmission of HIV-1 in women. Clinical and Experimental Immunology. (Posted: September 23, 2002) |
| HIV-1 integration in the human genome favors active genes and local hotspots. Cell. (Posted: September 23, 2002) |
| Subset of DC-SIGN(+) dendritic cells in human blood transmits HIV-1 to T lymphocytes. Blood. (Posted: September 23, 2002) |
| HIV testing and high risk sexual behaviour among London's migrant African communities. Sexually Transmitted Infections. (Posted: September 23, 2002) |
| NeuroAIDS: The central nervous system as a reservoir for simian immunodeficiency virus. The Journal of Infectious Diseases. (Posted: September 23, 2002) |
| Compartmentalization of HIV-1 between breast milk and blood of HIV-infected mothers. Virology. (Posted: September 23, 2002) |
| Oral administration of recombinant adeno-associated virus elicits HIV-specific immune responses. Human Gene Therapy. (Posted: September 23, 2002) |
| NeuroAIDS: Clinical implications of CNS penetration of antiretroviral drugs. CNS Drugs. (Posted: September 23, 2002) |
| Blocking of HIV-1 infection by targeting CD4 to nonraft membrane domains. Journal of Experimental Medicine. (Posted: September 23, 2002) |
| Continuing increases in sexual risk behavior and STDs among men who have sex with men. American Journal of Public Health. (Posted: September 17, 2002) |
| Effectiveness of interventions to prevent STIs and HIV in heterosexual men. Archives of Internal Medicine. (Posted: September 16, 2002) |
| Comparison of the efficacy of early versus late viral proteins in vaccination against SIV. Vaccine. (Posted: September 14, 2002) |
| NeuroAIDS: HIV-1 associated encephalopathy and myelopathy. Journal of Neurology. (Posted: September 14, 2002) |
| NeuroAIDS: Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance?. Trends in Neurosciences. (Posted: September 14, 2002) |
| Interactions of HIV-1 proteins with neurons. European Journal of Clinical Investigation. (Posted: September 14, 2002) |
| Enhancement of antibody responses to an HIV-2 DNA envelope vaccine. DNA and Cell Biology. (Posted: September 14, 2002) |
| T-cell response in rhesus macaques immunized with HIV gag DNA vaccines. Journal of Virology. (Posted: September 14, 2002) |
| Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine. Vaccine. (Posted: September 14, 2002) |
| Progression to AIDS, a clinical AIDS condition and mortality. Psychological Medicine. (Posted: September 14, 2002) |
| Does patient sex affect human immunodeficiency virus levels?. Clinical Infectious Diseases. (Posted: September 10, 2002) |
| Opportunistic infections in HIV-infected individuals: hepatitis C virus. Lancet. (Posted: September 7, 2002) |
| Considerations and development of topical microbicides to inhibit the sexual transmission of HIV. Expert Opinion on Investigational Drugs. (Posted: September 7, 2002) |
| Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection. Blood. (Posted: September 6, 2002) |
| NeuroAIDS: Effect of combination antiretroviral therapy on neurologic abnormalities. Journal of Pediatrics. (Posted: September 6, 2002) |
| T-cell response in rhesus macaques immunized with HIV gag DNA vaccines. Journal of Virology. (Posted: September 4, 2002) |
| Potent and specific inhibition of HIV-1 replication by RNA interference. Journal of Virology. (Posted: September 4, 2002) |
| NeuroAIDS: Development of a human neuronal cell model for HIV-infected macrophage-induced neurotoxicity. Journal of Virology. (Posted: September 4, 2002) |
| Continuing HIV transmission among injection drug users in Eastern Central Canada. Journal of Acquired Immune Deficiency Syndromes. (Posted: September 3, 2002) |
| A randomized trial with low-dose prolonged intermittent interleukin-2 adjuvant therapy. The Journal of Infectious Diseases. (Posted: September 3, 2002) |
| NeuroAIDS: Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annual Review of Neuroscience. (Posted: September 3, 2002) |
| NeuroAIDS: Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals. Neurology. (Posted: September 3, 2002) |
| Next generation DNA vaccines for HIV-1. Journal of Liposome Research. (Posted: September 3, 2002) |
| Recruiting volunteers for a multisite phase I/II HIV preventive vaccine trial in Thailand. Journal of Acquired Immune Deficiency Syndromes. (Posted: September 3, 2002) |
| Sexual behaviors in an urban bathhouse 15 years into the HIV epidemic. Journal of Acquired Immune Deficiency Syndromes. (Posted: September 3, 2002) |
| NeuroAIDS: PCNA expression as a marker of perivascular macrophages in SIV encephalitis. American Journal of Pathology. (Posted: September 3, 2002) |
| Increased peripheral expansion of naive CD4+T cells in vivo after IL-2 treatment of HIV patients. Proc. Natl. Acad. Sci. USA. (Posted: September 3, 2002) |
| DNA vaccines encoding HIV-1 gp120 fusions with proinflammatory chemoattractants. Blood. (Posted: September 3, 2002) |
| Clients of female sex workers in Nyanza province, Kenya — A core group in STD/HIV transmission. Sexually Transmitted Diseases. (Posted: August 29, 2002) |
| Design and tests of an HIV vaccine. British Medical Bulletin. (Posted: August 29, 2002) |
| Intention to notify sexual partners about potential HIV exposure among NYC STD clinics' clients. Sexually Transmitted Diseases. (Posted: August 29, 2002) |
| Mathematical models of vaccination. British Medical Bulletin. (Posted: August 29, 2002) |
| HIV-specific CD8 T-cell activity in uninfected injection drug users. AIDS. (Posted: August 24, 2002) |
| HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies. Proc. Natl. Acad. Sci. USA. (Posted: August 24, 2002) |
| Intranasal immunization protects against intravaginal challenge. Virology. (Posted: August 19, 2002) |
| Disulfide exchange in domain 2 of CD4 is required for entry of HIV-I. Nature Immunology. (Posted: August 19, 2002) |
| NeuroAIDS: AIDS dementia. Medical Clinics of North America. (Posted: August 19, 2002) |
| HIV-1 therapeutic vaccines. Journal of Infection. (Posted: August 19, 2002) |
| Semi-allogeneic vaccines for patients with cancer and AIDS. Journal of Immunotherapy. (Posted: August 19, 2002) |
| Cross-clade HIV-1-specific neutralizing IgA from HIV-1-exposed, persistently seronegative subjects. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 19, 2002) |
| HIV risk in a Mexican migrant community. American Journal of Public Health. (Posted: August 19, 2002) |
| SIVmac pathogenesis in rhesus macaques of Chinese and Indian origin. AIDS. (Posted: August 19, 2002) |
| Sexual risk behaviors and implications for secondary HIV transmission. AIDS. (Posted: August 19, 2002) |
| High-risk sexual behaviour increases among London gay men between 1998 and 2001. AIDS. (Posted: August 19, 2002) |
| The HIV-1 vaccine race. Cell. (Posted: August 19, 2002) |
| A Tat subunit vaccine confers protective immunity in mice. Proc. Natl. Acad. Sci. USA. (Posted: August 15, 2002) |
| Dendritic cell amplification of HIV type 1-specific CD8(+) T cell responses in seronegative women. AIDS Research and Human Retroviruses. (Posted: August 15, 2002) |
| Theoretical issues in the synthesis of HIV prevention research. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 15, 2002) |
| The HIV/AIDS Prevention Research Synthesis Project. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 15, 2002) |
| A profile of U.S.-based trials of behavioral and social interventions for HIV risk reduction. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 15, 2002) |
| Acquisition and review of non-U.S.-based HIV risk reduction intervention studies. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 15, 2002) |
| The Cochrane Collaborative Review Group on HIV Infection and AIDS. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 15, 2002) |
| A protocol for the analytical aspects of a systematic review of HIV prevention research. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 15, 2002) |
| A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 15, 2002) |
| Meta-analysis of the effects of behavioral HIV prevention interventions on adolescents. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 15, 2002) |
| Review and meta-analysis of HIV prevention intervention research for heterosexual adults. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 15, 2002) |
| HIV prevention research for men who have sex with men: a systematic review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 15, 2002) |
| The HIV/AIDS Prevention Research Synthesis Project: implications for federal HIV prevention policy. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 15, 2002) |
| Implications of the HIV/AIDS Prevention Research Synthesis Project on health departments. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 15, 2002) |
| HIV prevention research: Cumulative knowledge or accumulating studies?. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 15, 2002) |
| Safety of antiretroviral prophylaxis for HIV-infected pregnant women and their infants. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 9, 2002) |
| Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of resistance. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 9, 2002) |
| Breast-feeding and HIV-1 transmission in resource-limited settings. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 9, 2002) |
| Higher viral loads and other risk factors associated with HIV-1 seroconversion. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 9, 2002) |
| Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection. Journal of Acquired Immune Deficiency Syndromes. (Posted: August 9, 2002) |
| Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. (Posted: August 9, 2002) |
| HIV: A tough viral nut to crack. Nature. (Posted: August 9, 2002) |
| Antiretroviral-drug resistance among patients recently infected with HIV. New England Journal of Medicine. (Posted: August 8, 2002) |
| NeuroAIDS: GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia. Glia. (Posted: August 6, 2002) |
| Human immunodeficiency virus in correctional facilities: A review. Clinical Infectious Diseases. (Posted: August 6, 2002) |
| The crown and stem of the V3 loop in gp120 interactions with the CCR5 coreceptor. Journal of Virology. (Posted: August 6, 2002) |
| Generation of neutralizing activity against HIV-1 in serum by antibody gene transfer. Journal of Virology. (Posted: August 6, 2002) |
| Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of HIV-1. Journal of Virology. (Posted: August 6, 2002) |
| Patterns in the development of HIV-1-specific CD8+ T-cell responses. Journal of Virology. (Posted: August 6, 2002) |
| Sexual and drug use behavior among women who have sex with both women and men. American Journal of Public Health. (Posted: August 5, 2002) |
| Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?. Lancet Infectious Diseases. (Posted: August 2, 2002) |
| Molecular epidemiology of HIV-1; significance for vaccine development and therapy. Lancet Infectious Diseases. (Posted: August 2, 2002) |
| Prevalence, incidence, and mother-to-child transmission of HIV-1 in rural South Africa. Lancet. (Posted: August 2, 2002) |
| NeuroAIDS: Effect of combination anti retroviral therapy on CSF HIV RNA, HIV resistance, encephalopathy. Journal of Pediatrics. (Posted: August 2, 2002) |
| Evidence for a cytopathogenicity determinant in HIV-1 Vpr. Proc. Natl. Acad. Sci. USA. (Posted: August 2, 2002) |
| Modulation of HIV-1 replication by RNA interference. Nature. (Posted: August 2, 2002) |
| NeuroAIDS: Comparative lentiviral neuropathogenesis. Journal of Virology. (Posted: July 30, 2002) |
| HIV incidence on the increase among homosexual in Amsterdam STD clinic. AIDS. (Posted: July 29, 2002) |
| Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells. AIDS. (Posted: July 29, 2002) |
| The microbicide cyanovirin-N expressed on the surface of a commensal bacterium. AIDS. (Posted: July 29, 2002) |
| Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission. AIDS. (Posted: July 29, 2002) |
| Increased risk of HIV and STD transmission among gay or bisexual men who use Viagra. AIDS. (Posted: July 29, 2002) |
| Strategies for an HIV vaccine. Journal of Clinical Investigation. (Posted: July 29, 2002) |
| The development of HIV-1 subtype C vaccines for southern Africa. IUBMB Life. (Posted: July 29, 2002) |
| Alphavirus replicon particles as candidate HIV vaccines. IUBMB Life. (Posted: July 29, 2002) |
| Epidermal powder immunization with a recombinant HIV gp120. AIDS Research and Human Retroviruses. (Posted: July 29, 2002) |
| Recombination: Multiply infected spleen cells in HIV patients. Nature. (Posted: July 29, 2002) |
| Meeting international goals in child survival and HIV/AIDS. Lancet. (Posted: July 25, 2002) |
| NeuroAIDS: Primary isolated human brain MVECs express diverse chemokine coreceptors and DC-SIGN and L-SIGN. Virology. (Posted: July 24, 2002) |
| T-lymphocyte epitope identification and their use in vaccine development for HIV-1. Frontiers in Bioscience. (Posted: July 24, 2002) |
| Douching practices among women at high risk of HIV infection in the United States. Sexually Transmitted Diseases. (Posted: July 24, 2002) |
| NeuroAIDS: Simian immunodeficiency virus encephalitis. Virology. (Posted: July 24, 2002) |
| Public perception of the risk of HIV infection associated with blood donation. Transfusion. (Posted: July 24, 2002) |
| Immuno-informatics: Mining genomes for vaccine components. Immunology and Cell Biology. (Posted: July 24, 2002) |
| Experts predict global devastation due to HIV/AIDS. Lancet. (Posted: July 24, 2002) |
| Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nature Genetics. (Posted: July 23, 2002) |
| Mechanisms of protection induced by attenuated simian immunodeficiency virus. Virology. (Posted: July 19, 2002) |
| NeuroAIDS: Central and peripheral nervous system functions are independently disturbed in HIV patients. Journal of Neurology. (Posted: July 19, 2002) |
| Immunization with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen. Journal of Virology. (Posted: July 19, 2002) |
| Enhanced Presentation of MHC Class I-Restricted HIV-1 Gag-Specific Epitopes after DNA Immunization. Journal of Virology. (Posted: July 19, 2002) |
| Mucosal immunity induced by intramuscular administration of free peptides in-line with PADRE. Scandinavian Journal of Immunology. (Posted: July 19, 2002) |
| Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy. Nature Medicine. (Posted: July 19, 2002) |
| siRNA-directed inhibition of HIV-1 infection. Nature Medicine. (Posted: July 19, 2002) |
| Avoiding the kiss of death: how HIV and other chronic viruses survive. Current Opinion in Immunology. (Posted: July 19, 2002) |
| Promises and pitfalls in the reconstitution of immunity in patients who have HIV-1 infection. Current Opinion in Immunology. (Posted: July 19, 2002) |
| Neutralizing antibodies against HIV — back in the major leagues?. Current Opinion in Immunology. (Posted: July 19, 2002) |
| Producing a highly immunogenic synthetic vaccine construct active against HIV-1 subtype C. Vaccine. (Posted: July 19, 2002) |
| NeuroAIDS: Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology. (Posted: July 19, 2002) |
| Private demand for a HIV/AIDS vaccine: evidence from Guadalajara, Mexico. Vaccine. (Posted: July 19, 2002) |
| Spontaneous production of RANTES and antigen-specific IFN-gamma production in vaccinated macaques. Clinical and Experimental Immunology. (Posted: July 19, 2002) |
| Reasons for not using condoms among the Hong Kong Chinese population. Sexually Transmitted Infections. (Posted: July 19, 2002) |
| AIDS Vaccination Studies Using an Ex Vivo Feline Immunodeficiency Virus Model. Journal of Virology. (Posted: July 19, 2002) |
| Memory T-Cell Responses Induced by Prime-Boost Regimens with Heterologous Live Viral Vectors. Journal of Virology. (Posted: July 19, 2002) |
| Similar Control of a SHIV 89.6P Mucosal Challenge by MVA and DNA/MVA Vaccines. Journal of Virology. (Posted: July 19, 2002) |
| Preventing mother-to-child HIV transmission — The first year of Thailand's national program. Journal of the American Medical Association. (Posted: July 19, 2002) |
| NeuroAIDS: Relationships between cognition and structural neuroimaging findings in adults with HIV-1. Neuroscience and Biobehavioral Reviews. (Posted: July 19, 2002) |
| Human Immunodeficiency Virus-Specific CD8+ T Cells in Human Breast Milk. Journal of Virology. (Posted: July 19, 2002) |
| Intersubtype HIV-1 Superinfection following Seroconversion to Primary Infection. Journal of Virology. (Posted: July 19, 2002) |
| Diagnosis and Reporting of HIV and AIDS in States with HIV/AIDS Surveillance. MMWR. (Posted: July 11, 2002) |
| NeuroAIDS: Human brain microvascular endothelial cells express chemokine coreceptors and DC-SIGN and L-SIGN. Virology. (Posted: July 11, 2002) |
| Update: AIDS — United States, 2000. MMWR. (Posted: July 11, 2002) |
| NeuroAIDS: HIV-1 enters brain microvascular endothelia by macropinocytosis. Journal of Virology. (Posted: July 9, 2002) |
| NeuroAIDS: Local perceptions of the mental health effects of the Uganda AIDS epidemic. Journal of Nervous and Mental Disease. (Posted: July 9, 2002) |
| Evaluating the risk of HIV transmission through unprotected orogenital sex. AIDS. (Posted: July 9, 2002) |
| NeuroAIDS: Expression of stromal cell-derived factor 1 alpha protein in HIV encephalitis. Journal of Neuroimmunology. (Posted: July 9, 2002) |
| NeuroAIDS: Neurologic and psychiatric complications of antiretroviral agents. AIDS. (Posted: July 9, 2002) |
| Real-time, universal screening for acute HIV infection. Journal of the American Medical Association. (Posted: July 8, 2002) |
| Hepatitis C and Progression of HIV Disease. Journal of the American Medical Association. (Posted: July 8, 2002) |
| Declining HIV-1 incidence and associated prevalence over 10 years in Uganda. Lancet. (Posted: July 5, 2002) |
| The economics of HIV in Africa (editorial). Lancet. (Posted: July 5, 2002) |
| Evidence of success in HIV prevention in Africa (commentary). Lancet. (Posted: July 5, 2002) |
| Can we reverse the HIV/AIDS pandemic with an expanded response?. Lancet. (Posted: July 5, 2002) |
| The Ugandan success story? Evidence and claims of HIV-1 prevention (viewpoint). Lancet. (Posted: July 5, 2002) |
| Shadow on the continent: public health and HIV/AIDS in Africa in the 21st century. Lancet. (Posted: July 5, 2002) |
| NeuroAIDS: HIV-1 and the central nervous system. Current Topics in Microbiology and Immunology. (Posted: July 5, 2002) |
| NeuroAIDS: Pathogenic and nef-interrupted SHIV traffic to the macaque CNS and cause astrocytosis. Virology. (Posted: July 5, 2002) |
| Induction of a strong HIV-specific CD8(+) T cell response in mice using a fowlpox virus vector. Viral Immunology. (Posted: July 5, 2002) |
| SHIV chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection. Archives of Virology. (Posted: July 5, 2002) |
| NeuroAIDS: Cyclooxygenase-2-positive macrophages infiltrate the AD brain and damage the blood-brain barrier. European Journal of Clinical Investigation. (Posted: July 5, 2002) |
| Detection of replication-competent HIV-1 in cultures from patients with low RNA levels. Journal of Clinical Microbiology. (Posted: July 1, 2002) |
| NeuroAIDS: Discordant HIV-1 drug resistance mutations, including K103N, observed in CSF and plasma. Clinical Infectious Diseases. (Posted: July 1, 2002) |
| NeuroAIDS: Prediction of progression to neuropsychological impairment in HIV infection. Archives of Neurology. (Posted: June 28, 2002) |
| Design and validation of an ELISPOT for use in clinical trials of candidate HIV vaccines. AIDS Research and Human Retroviruses. (Posted: June 28, 2002) |
| Association of a pool of HIV-1 with erythrocytes in vivo: a cohort study. Lancet. (Posted: June 28, 2002) |
| Comparison of HIV-specific infection-enhancing and -inhibiting antibodies in AIDS patients. Journal of Clinical Microbiology. (Posted: June 28, 2002) |
| HIV/AIDS treatment and HIV vaccines for Africa. Lancet. (Posted: June 28, 2002) |
| Enhanced inhibition of HIV-1 replication by novel lentiviral vectors. Human Gene Therapy. (Posted: June 28, 2002) |
| NeuroAIDS: Macaque animal model for HIV-induced neurological disease. Journal of Neural Transmission. (Posted: June 28, 2002) |
| NeuroAIDS: Parkinsonism in HIV dementia. Journal of Neural Transmission. (Posted: June 28, 2002) |
| NeuroAIDS: CSF viral load measurements and the pathogenesis of HIV infection of the CNS. Archives of Neurology. (Posted: June 28, 2002) |
| Diversity considerations in HIV-1 vaccine selection. Science. (Posted: June 28, 2002) |
| HIV-1 diversity and vaccine development. Science. (Posted: June 28, 2002) |
| China and AIDS—The time to act is now. Science. (Posted: June 28, 2002) |
| Free formula milk for infants of HIV-infected women: blessing or curse?. Health Policy and Planning. (Posted: June 27, 2002) |
| Estimating the cost of unmet HIV-prevention needs in the United States. American Journal of Preventive Medicine. (Posted: June 26, 2002) |
| B cell activation in peripheral blood and lymph nodes during HIV infection. AIDS. (Posted: June 26, 2002) |
| HIV incidence on the increase among homosexual men attending an STD clinic. AIDS. (Posted: June 26, 2002) |
| Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells. AIDS. (Posted: June 26, 2002) |
| Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission. AIDS. (Posted: June 26, 2002) |
| No effect of therapeutic vaccination with HIV-1 p17/p24. Vaccine. (Posted: June 25, 2002) |
| The risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT. Transfusion. (Posted: June 25, 2002) |
| Evaluation of SIV library vaccines with genetic cytokines in a macaque challenge. Vaccine. (Posted: June 25, 2002) |
| Stimulation of both humoral and cellular immune responses to HIV-1 gp120 by IL-12 in Rhesus macaques. Vaccine. (Posted: June 25, 2002) |
| The spread and effect of HIV-1 infection in sub-Saharan Africa. Lancet. (Posted: June 21, 2002) |
| Resistance to mucosal SIV infection is associated with a postentry block in viral replication. Journal of Virology. (Posted: June 21, 2002) |
| Critical role for Env as well as Gag-Pol in control of a SHIV 89.6P challenge. Journal of Virology. (Posted: June 21, 2002) |
| Prior vaccination increases CTL epitopic breadth of response following a SHIV infection. Journal of Virology. (Posted: June 21, 2002) |
| HIV-1/AIDS and the control of other infectious diseases in Africa. Lancet. (Posted: June 21, 2002) |
| Molecular surveillance of HIV-1 field strains in Nigeria in preparation for vaccine trials . Vaccine. (Posted: June 21, 2002) |
| Summary of the updated U.S. PHS recommendations to reduce perinatal HIV-1 transmission. Obstetrics and Gynecology. (Posted: June 21, 2002) |
| NeuroAIDS: Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary HIV-1 isolate. Journal of Virology. (Posted: June 21, 2002) |
| Inefficient enhancement of viral infectivity and CD4 downregulation by HIV-1 nef from Japanese LTNPs. Journal of Virology. (Posted: June 21, 2002) |
| Identification and characterization of thymic epithelial progenitor cells. Immunity. (Posted: June 19, 2002) |
| Cardiovascular status of infants and children of women infected with HIV-1: a cohort study. Lancet. (Posted: June 18, 2002) |
| Generation of a complete thymic microenvironment by MTS24+ thymic epithelial cells. Nature Immunology. (Posted: June 18, 2002) |
| Risky sexual behaviours among injection drugs users with high HIV prevalence. Sexually Transmitted Infections. (Posted: June 17, 2002) |
| A pilot study of a rapid assessment method to identify places for AIDS prevention. Sexually Transmitted Infections. (Posted: June 17, 2002) |
| HIV-1/AIDS and maternal and child health in Africa. Lancet. (Posted: June 14, 2002) |
| Decreasing STD incidence and increasing condom use among Chinese sex workers. Sexually Transmitted Infections. (Posted: June 12, 2002) |
| Post-exposure prophylaxis for non-occupational exposure to HIV. Sexually Transmitted Infections. (Posted: June 12, 2002) |
| Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab that binds gp120-CD4-CCR5 complexes. Proc. Natl. Acad. Sci. USA. (Posted: June 12, 2002) |
| The replication of HIV-1 in macrophages is enhanced after phagocytosis of apoptotic cells. The Journal of Infectious Diseases. (Posted: June 12, 2002) |
| Characterization of CD4(+) CTLs ex vivo . Journal of Immunology. (Posted: June 12, 2002) |
| Sexual and drug risk-related behaviours after initiating HAART among injection drug users. AIDS. (Posted: June 12, 2002) |
| Human immunodeficiency virus type 2. Journal of General Virology. (Posted: June 12, 2002) |
| NeuroAIDS: In vitro and animal models of human immunodeficiency virus infection of the central nervous system. Clinical and Diagnostic Laboratory Immunology. (Posted: June 12, 2002) |
| NeuroAIDS: Caspase cascades in human immunodeficiency virus-associated neurodegeneration. Journal of Neuroscience. (Posted: June 12, 2002) |
| NeuroAIDS: Methamphetamine enhances neurotoxicity and brain viral load in FIV infected cats. Journal of Neurovirology. (Posted: June 7, 2002) |
| Media coverage of scientific meetings — Too much, too Soon?. Journal of the American Medical Association. (Posted: June 6, 2002) |
| HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigens. AIDS. (Posted: June 4, 2002) |
| Spare non-occupational HIV PEP by active contacting and testing of the source person. AIDS. (Posted: June 4, 2002) |
| Short interfering RNA-directed inhibition of HIV-1 infection. Nature Medicine. (Posted: June 3, 2002) |
| NeuroAIDS: Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors. Archives of Neurology. (Posted: June 1, 2002) |
| Risk-taking behaviors among injecting drug users who obtain syringes legally. Journal of Urban Health. (Posted: June 1, 2002) |
| Special issue of the journal Vaccine: several titles. Vaccine. (Posted: June 1, 2002) |
| HIV prevention before HAART in sub-Saharan Africa. Lancet. (Posted: June 1, 2002) |
| Europe is complacent over HIV. British Medical Journal. (Posted: May 31, 2002) |
| Are trends in HIV, gonorrhoea, and syphilis worsening in western Europe?. British Medical Journal. (Posted: May 31, 2002) |
| Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe. Lancet. (Posted: May 31, 2002) |
| Intermittent use of triple-combination therapy is predictive of mortality. AIDS. (Posted: May 29, 2002) |
| Unstimulated CD8+ T lymphocytes from HIV-EU individuals inhibit HIV-1. AIDS. (Posted: May 29, 2002) |
| Association of HIV-1 viral phenotype in the MT-2 assay with perinatal HIV transmission. Journal of Acquired Immune Deficiency Syndromes. (Posted: May 29, 2002) |
| Combination antiretroviral strategies reduce perinatal HIV-1 transmission. Journal of Acquired Immune Deficiency Syndromes. (Posted: May 29, 2002) |
| NeuroAIDS: Innate differences between SHIV-infected rhesus and pig-tailed Macaques in development of neuroAIDS. Virology. (Posted: May 29, 2002) |
| HIV-1 subtype C molecular phylogeny: Consensus sequence for an AIDS vaccine design?. Journal of Virology. (Posted: May 29, 2002) |
| Modifications of the HIV envelope glycoprotein enhance immunogenicity for genetic immunization. Journal of Virology. (Posted: May 29, 2002) |
| NeuroAIDS: Proinflammatory cytokines in the CNS are associated with neuroinvasion by SIV and neuroAIDS. Journal of Virology. (Posted: May 29, 2002) |
| NeuroAIDS: Generation of cytotoxic T cells against virus-infected human brain macrophages. Journal of Immunology. (Posted: May 25, 2002) |
| NeuroAIDS: Correlation between percentage of brain parenchymal volume and neurocognitive performance. American Journal of Neuroradiology. (Posted: May 25, 2002) |
| Reduced HIV risk-taking and low HIV incidence after counseling. Journal of Acquired Immune Deficiency Syndromes. (Posted: May 25, 2002) |
| Risk networks and racial/ethnic differences in the prevalence of HIV infection among IDUs. Journal of Acquired Immune Deficiency Syndromes. (Posted: May 25, 2002) |
| Protease inhibitor combination therapy and decreased condom use among gay men. Southern Medical Journal. (Posted: May 24, 2002) |
| Highlights from the 2002 STD Conference. Medscape Infectious Diseases. (Posted: May 24, 2002) |
| Better Remune response in patients with low viral loads and high CD4 cell counts. Clinical and Experimental Immunology. (Posted: May 24, 2002) |
| Persistent HIV-1 infection of natural killer cells in patients receiving HAART. Proc. Natl. Acad. Sci. USA. (Posted: May 24, 2002) |
| Time to AIDS from 1992 to 1999 in HIV-1-infected subjects with known date of infection. Journal of Acquired Immune Deficiency Syndromes. (Posted: May 22, 2002) |
| Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nature Medicine. (Posted: May 20, 2002) |
| Prevalence of and risk factors for HIV infection in Ethiopia. Epidemiology and Infection. (Posted: May 20, 2002) |
| NeuroAIDS: Involvement of brain cytokines in the neurobehavioral disturbances induced by HIV-1 gp120. Brain Research. (Posted: May 20, 2002) |
| Mother-to-child HIV type 1 transmission in Argentina. AIDS Research and Human Retroviruses. (Posted: May 20, 2002) |
| Fusion-competent vaccines (Retraction of vol 283, pg 357, 1999). Science. (Posted: May 20, 2002) |
| Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Morbidity and Mortality Weekly Report. (Posted: May 16, 2002) |
| Osteonecrosis of the hip in human immunodeficiency virus-infected children. Pediatrics. (Posted: May 15, 2002) |
| The Tat protein of HIV can suppress later DNA polymerization in HIV-1 reverse transcription. Journal of Virology. (Posted: May 15, 2002) |
| CRF06-cpx: a new circulating recombinant form of HIV-1 in West Africa. Journal of Acquired Immune Deficiency Syndromes. (Posted: May 15, 2002) |
| Identification of a newly characterized HIV-1 BG intersubtype recombinant in Galicia, Spain. Journal of Acquired Immune Deficiency Syndromes. (Posted: May 15, 2002) |
| Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab. Proc. Natl. Acad. Sci. USA. (Posted: May 14, 2002) |
| Issues for improving multiplasmid DNA vaccines for HIV-1. Vaccine. (Posted: May 14, 2002) |
| HIV in Africa — Chemokine-receptor genes and AIDS risk. Nature. (Posted: May 14, 2002) |
| HIV-1 neutralization measured by flow cytometric quantitation. Journal of Virology. (Posted: May 14, 2002) |
| NeuroAIDS: Early psychomotor slowing predicts the development of HIV dementia. Acta Neurologica Scandinavica. (Posted: May 14, 2002) |
| Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet. (Posted: May 14, 2002) |
| HAART treatment does not increase sexual risk behaviour among French HIV infected IDUs. Journal of Epidemiology and Community Health. (Posted: May 10, 2002) |
| Factors associated with persistent high-risk syringe sharing in the presence of an established NEP. AIDS. (Posted: May 10, 2002) |
| Implementation of an Italian multicentric care network for early HIV infection diagnosis. J. Biol. Regul. Homeost. Agents. (Posted: May 10, 2002) |
| NeuroAIDS: Early brain atrophy in HIV infection: a radiological-stereological study. Neuroradiology. (Posted: May 10, 2002) |
| Lessons for mother-to-child HIV transmission prevention programmes. AIDS. (Posted: May 10, 2002) |
| Researchers Use Gene Therapy to Destroy HIV. Nature Biotechnology. (Posted: May 9, 2002) |
| Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999. Journal of Acquired Immune Deficiency Syndromes. (Posted: May 9, 2002) |
| HIV and AIDS risk behaviors among female jail detainees. American Journal of Public Health. (Posted: May 8, 2002) |
| Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HAN. Nature Medicine. (Posted: May 8, 2002) |
| Disrupted homeostasis of Langerhans cells and interdigitating dendritic cells in monkeys with AIDS. Blood. (Posted: May 8, 2002) |
| HIV-1 shedding in genital tract of infected women. Lancet. (Posted: May 8, 2002) |
| Prospects for an AIDS vaccine (letter). Science. (Posted: May 7, 2002) |
| NeuroAIDS: Disappearance of an intracerebral arteriovenous malformation after initiation of HAART. Infection. (Posted: May 7, 2002) |
| Prospects for vaccine protection against HIV-1 infection and AIDS. Annual Review of Immunology. (Posted: May 7, 2002) |
| Effect of gp120 V3 loop deletion on cellular responses and protection against challenge. Journal of Virology. (Posted: May 7, 2002) |
| NeuroAIDS: Generation of cytotoxic T cells against virus-infected human brain macrophages. Journal of Immunology. (Posted: May 7, 2002) |
| Maternal HIV-1 antibody and vertical transmission in subtype C virus infection. Journal of Acquired Immune Deficiency Syndromes. (Posted: May 7, 2002) |
| Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women. Journal of Acquired Immune Deficiency Syndromes. (Posted: May 7, 2002) |
| Evaluation of a non-name-based HIV reporting system in San Francisco. Journal of Acquired Immune Deficiency Syndromes. (Posted: May 7, 2002) |
| Spectrum of commercial sex activity in Burkina Faso. Journal of Acquired Immune Deficiency Syndromes. (Posted: May 7, 2002) |
| NeuroAIDS: Macrophages, chemokines and neuronal injury in HIV-1-associlated dementia. Cellular and Molecular Biology. (Posted: May 7, 2002) |
| Comparison of vaccine strategies using recombinant env-gag-pol MVA. Virology. (Posted: May 7, 2002) |
| NeuroAIDS: Effect of GP120 on glutathione peroxidase activity in cortical cultures. Journal of Neurochemistry. (Posted: May 7, 2002) |
| Immune response and virus population composition: HIV as a case study. Proceedings of the Royal Society of London. (Posted: May 7, 2002) |
| HIV preferentially infects HIV-specific CD4+ T cells. Nature. (Posted: May 2, 2002) |
| HIV seroincidence among patients at clinics for sexually transmitted disease. Journal of Acquired Immune Deficiency Syndromes. (Posted: May 2, 2002) |
| Filgrastim seems to increase survival in AIDS patients. AIDS. (Posted: May 2, 2002) |
| NeuroAIDS: Connections between HIV-1-associated dementia, neuropathology and neuroimmunology. Microbes and Infection. (Posted: April 25, 2002) |
| Condom use and sexual behaviors among individuals procuring free male condoms in South Africa. Sexually Transmitted Diseases. (Posted: April 25, 2002) |
| Stimulation of local antibody production: parenteral or mucosal vaccination?. Trends in Immunology. (Posted: April 25, 2002) |
| A cationic sub-micron emulsion (MF59/DOTAP) is an effective delivery system for DNA vaccines. Journal of Controlled Release. (Posted: April 25, 2002) |
| NeuroAIDS: Clinical aspects of the AIDS dementia complex. European Neurology. (Posted: April 25, 2002) |
| MDMA ('ecstasy') use and its association with high risk behaviors. Drug and Alcohol Dependence. (Posted: April 25, 2002) |
| Attitudes towards HAART are associated with sexual risk taking. AIDS. (Posted: April 25, 2002) |
| Virologic risk factors for vertical transmission of HIV type 1 in Puerto Rico. AIDS Research and Human Retroviruses. (Posted: April 25, 2002) |
| Vitamin A supplementation and HIV-1 shedding in women. Journal of Infectious Diseases. (Posted: April 24, 2002) |
| Older children and adolescents surviving with vertically acquired HIV infection. Journal of Acquired Immune Deficiency Syndromes. (Posted: April 24, 2002) |
| Identifying undiagnosed human immunodeficiency virus. Archives of Internal Medicine. (Posted: April 22, 2002) |
| NeuroAIDS: Progression of HIV-associated dementia treated with HAART. The AIDS Reader. (Posted: April 19, 2002) |
| Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. Canadian Medical Association Journal. (Posted: April 18, 2002) |
| Aiming for zero: preventing mother-to-child transmission of HIV. Canadian Medical Association Journal. (Posted: April 18, 2002) |
| HIV incidence among injection drug users in Vancouver. Canadian Medical Association Journal. (Posted: April 18, 2002) |
| Epidemiology of HIV in China. British Medical Journal. (Posted: April 18, 2002) |
| NeuroAIDS: Neuropsychiatric aspects of HIV disease progression. Prog. Neuro-Psych. Biol. Psych.. (Posted: April 18, 2002) |
| Diversity of HIV-1 subtype E in semen and cervicovaginal secretion. Journal of Human Virology. (Posted: April 18, 2002) |
| Assessment of a rapid HIV test strategy during labor - A pilot study from Rio de Janeiro, Brazil. Journal of Human Virology. (Posted: April 18, 2002) |
| Global fund for AIDS, TB and malaria opens shop. Bulletin of the World Health Organization. (Posted: April 18, 2002) |
| Zidovudine and perinatal HIV-1 transmission: A population-based approach. Pediatrics. (Posted: April 18, 2002) |
| Is human immunodeficiency virus RNA load composed of neutralized immune complexes?. The Journal of Infectious Diseases. (Posted: April 18, 2002) |
| NeuroAIDS: Children with neurological abnormalities and rapid disease progression. Journal of Medical Virology. (Posted: April 18, 2002) |
| HIV-1 epidemic among female bar and hotel workers in northern Tanzania. Journal of Acquired Immune Deficiency Syndromes. (Posted: April 18, 2002) |
| Mothers, orphans, and prevention of paediatric AIDS. Lancet. (Posted: April 18, 2002) |
| Reduction of mother to child HIV-1 transmission. Lancet. (Posted: April 18, 2002) |
| Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein. Journal of Biological Chemistry. (Posted: April 18, 2002) |
| NeuroAIDS: The impact of efflux transporters in the brain on the development of drugs for CNS disorders. Clinical Pharmacokinetics. (Posted: April 18, 2002) |
| HIV vaccine development in the nonhuman primate model of AIDS. Journal of Biomedical Science. (Posted: April 18, 2002) |
| Failure to prevent perinatal HIV infection. Canadian Medical Association Journal. (Posted: April 18, 2002) |
| Outcome of SIV strain 89.6p challenge following vaccination of rhesus macaques with HIV Tat protein. Journal of Virology. (Posted: April 11, 2002) |
| Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication. Journal of Virology. (Posted: April 11, 2002) |
| Does a history of trauma contribute to HIV risk for women of color?. American Journal of Public Health. (Posted: April 11, 2002) |
| Immunization with recombinant MVA can modify mucosal SIV infection and delay disease progression. Journal of General Virology. (Posted: April 11, 2002) |
| NeuroAIDS: Destabilization of neuronal calcium homeostasis by macrophage cultures in response to FIV. Neurobiology of Disease. (Posted: April 11, 2002) |
| HIV-1 polymorphism: A challenge for vaccine development - A review. Memorias do Instituto Oswaldo Cruz. (Posted: April 11, 2002) |
| Dynamics of T cell responses in HIV infection. Journal of Immunology. (Posted: April 11, 2002) |
| Gag protein and p24 capsid subunit would optimize anti-HIV-1 vaccine. Journal of Virology. (Posted: April 11, 2002) |
| Vertical HIV transmission in South Africa: translating research into policy and practice. Lancet. (Posted: April 5, 2002) |
| HIV-associated histories, perceptions, and practices among low-income African American women. American Journal of Public Health. (Posted: April 5, 2002) |
| Twenty-four month efficacy of a maternal short-course zidovudine regimen. AIDS. (Posted: April 3, 2002) |
| NeuroAIDS: Progressive multifocal leukoencephalopathy limited to the brain stem. Neuroradiology. (Posted: April 3, 2002) |
| Clinical trials of HIV vaccines. Annual Review of Medicine. (Posted: April 3, 2002) |
| Viral persistence: HIV's strategies of immune system evasion. Annual Review of Medicine. (Posted: April 3, 2002) |
| Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand. Journal of Acquired Immune Deficiency Syndromes. (Posted: April 3, 2002) |
| Incidence of HIV-1 infection and effects of clinic-based counseling on HIV preventive behaviors. Journal of Acquired Immune Deficiency Syndromes. (Posted: April 3, 2002) |
| Use of a public sexually transmitted disease clinic by known HIV-positive adults. Journal of Acquired Immune Deficiency Syndromes. (Posted: April 3, 2002) |
| NeuroAIDS: Abnormal cobalamin-dependent transmethylation in AIDS-associated myelopathy. Neurology. (Posted: April 3, 2002) |
| Induction of mucosal protection against primary, heterologous SIV by a DNA vaccine. Journal of Virology. (Posted: April 3, 2002) |
| NeuroAIDS: Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. Journal of Virology. (Posted: April 3, 2002) |
| The dual role of CD4 T helper cells in the infection dynamics and vaccination. Journal of Theoretical Biology. (Posted: April 3, 2002) |
| NeuroAIDS: Macrophages relate presynaptic and postsynaptic damage in simian immunodeficiency virus encephalitis. American Journal of Pathology. (Posted: April 3, 2002) |
| Pathways to HIV testing and care by black African and white patients in London. Sexually Transmitted Infections. (Posted: April 3, 2002) |
| Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120. Journal of Acquired Immune Deficiency Syndromes. (Posted: April 3, 2002) |
| From the apprehension of sexually transmissible diseases to the prevention of HIV. Presse Medicale. (Posted: April 3, 2002) |
| Immunologic control of HIV-1. Annual Review of Medicine. (Posted: April 3, 2002) |
| Immune reconstitution in patients with HIV infection. Annual Review of Medicine. (Posted: April 3, 2002) |
| Potential new therapies for the treatment of HIV-1 infection. Annual Review of Medicine. (Posted: April 3, 2002) |
| Meeting the contraceptive and AIDS prevention needs of people living on a dollar a day. Reproduction Fertility and Development. (Posted: April 3, 2002) |
| NeuroAIDS: Recurrent stroke as a manifestation of primary angiitis of the CNS in a patient infected with HIV. Archives of Neurology. (Posted: April 3, 2002) |
| HIV type 1-specific IgE in serum of long-term surviving children inhibits HIV type 1 production. AIDS Research and Human Retroviruses. (Posted: April 3, 2002) |
| NeuroAIDS: Impaired spatial cognition and synaptic potentiation in a murine model of HIV-1 encephalitis. Journal of Neuroscience. (Posted: April 3, 2002) |
| NeuroAIDS: Cell cycle proteins exhibit altered expression patterns in lentiviral-associated encephalitis. Journal of Neuroscience. (Posted: April 3, 2002) |
| NeuroAIDS: Involvement of dopamine in the progression of AIDS Dementia Complex. Journal of Neural Transmission. (Posted: April 3, 2002) |
| Viral dynamics of early HIV infection in neonatal macaques after oral exposure to HIV-2. Journal of Medical Primatology. (Posted: April 3, 2002) |
| DNA prime/protein boost vaccine strategy in neonatal macaques against SHIV. Journal of Medical Primatology. (Posted: April 3, 2002) |
| 'Barebacking' in a diverse sample of men who have sex with men. AIDS. (Posted: April 3, 2002) |
| Prospects of vaccination as a means of preventing mother-to-child transmission of HIV-I. Acta Paediatrica. (Posted: April 3, 2002) |
| Oral DNA vaccination in utero induces mucosal immunity and immune memory in the neonate. Journal of Immunology. (Posted: March 28, 2002) |
| Measures to reduce HIV infection do not reduce the prevalence of HCV in intravenous drug users. European Journal of Epidemiology. (Posted: March 24, 2002) |
| Modelling HIV/AIDS epidemics in Botswana and India: impact of interventions to prevent transmission. Bulletin of the World Health Organization. (Posted: March 24, 2002) |
| AIDS vaccine models: Challenging challenge viruses. Nature Medicine. (Posted: March 24, 2002) |
| NeuroAIDS: Brainstem auditory evoked response in HIV-infected patients with and without AIDS. Archives of Medical Research. (Posted: March 24, 2002) |
| NeuroAIDS: A co-culture-based model of human blood-brain barrier. Brain Research. (Posted: March 24, 2002) |
| Diagnostic detection of human immunodeficiency virus type 1 antibodies in urine: a Brazilian study. Journal of Clinical Microbiology. (Posted: March 24, 2002) |
| HIV enhances substance P expression in human immune cells. FASEB Journal. (Posted: March 24, 2002) |
| Ethics in international health research: a perspective from the developing world. Bulletin of the World Health Organization. (Posted: March 24, 2002) |
| Recent experience with HIV transmission by cellular blood products in Germany. Vox Sanguinis. (Posted: March 24, 2002) |
| Emergence of neutralization-resistant HIV variants during virus rebound in HAART. The Journal of Infectious Diseases. (Posted: March 14, 2002) |
| Antibody screening is not sufficient to prevent transmission. Vox Sanguinis. (Posted: March 13, 2002) |
| HIV-related stigma and knowledge in the United States: prevalence and trends, 1991--1999. American Journal of Public Health. (Posted: March 13, 2002) |
| Changing risk factors for HIV infection. Archives of Medical Research. (Posted: March 13, 2002) |
| NeuroAIDS: A co-culture-based model of human blood-brain barrier. Brain Research. (Posted: March 13, 2002) |
| NeuroAIDS: Seizures in HIV-seropositive individuals — Epidemiology and treatment. CNS Drugs. (Posted: March 13, 2002) |
| High-level primary CD8(+) T-cell response to HIV-1 generated by vaccination with VSV. Journal of Virology. (Posted: March 13, 2002) |
| NeuroAIDS: Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels. AIDS. (Posted: March 13, 2002) |
| NeuroAIDS: GM-CSF enhances viral load in human brain tissue: amelioration with stavudine. AIDS. (Posted: March 13, 2002) |
| Decline in the prevalence of HIV and STDs among female sex workers in Cotonou, Benin, 1993-1999. AIDS. (Posted: March 13, 2002) |
| HIV incidence and associated risk factors among young injection drug users. AIDS. (Posted: March 13, 2002) |
| Independent effects of reported STDs and sexual behavior on HIV-1 prevalence. Journal of Acquired Immune Deficiency Syndromes. (Posted: March 13, 2002) |
| Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. Journal of Acquired Immune Deficiency Syndromes. (Posted: March 13, 2002) |
| Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies. American Journal of Public Health. (Posted: March 13, 2002) |
| Changes in HIV seroprevalence and related behaviors among male injection drug users. American Journal of Public Health. (Posted: March 13, 2002) |
| Post-exposure prophylaxis after non-occupational HIV exposure. AIDS. (Posted: March 13, 2002) |
| Extending the methodology of the Committee on Clinical Preventive Service Priorities. American Journal of Preventive Medicine. (Posted: March 12, 2002) |
| Post-exposure prophylaxis after non-occupational HIV exposure. AIDS. (Posted: March 4, 2002) |
| NeuroAIDS: GM-CSF enhances viral load in human brain tissue: amelioration with stavudine. AIDS. (Posted: March 4, 2002) |
| Decrease in HIV-1 seminal shedding in men receiving HAART: an 18 month longitudinal study. AIDS. (Posted: March 4, 2002) |
| HIV incidence and associated risk factors among young injection drug users. AIDS. (Posted: March 4, 2002) |
| The impact of a partially effective HIV vaccine on a population of IV drug users. Journal of Acquired Immune Deficiency Syndromes. (Posted: March 4, 2002) |
| The macrophage in HIV infection. Immunobiology. (Posted: March 4, 2002) |
| Dendritic cells and HIV infection. Immunobiology. (Posted: March 4, 2002) |
| The HIV/AIDS vaccine researchers' orientation to the process of preparing a US FDA application. Vaccine. (Posted: March 4, 2002) |
| Immunization strategies to augment oral vaccination with DNA and viral vectors. Vaccine. (Posted: March 4, 2002) |
| Vaccine development against HIV-1 - Current perspectives and future directions. Immunologic Research. (Posted: March 4, 2002) |
| Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly HIV-1-infected patients. Journal of Virology. (Posted: March 4, 2002) |
| NeuroAIDS: Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels. AIDS. (Posted: March 4, 2002) |
| Decline in the prevalence of HIV and STDs among female sex workers in Cotonou, Benin, 1993-1999. AIDS. (Posted: March 4, 2002) |
| Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant SIV epitopes. Journal of Immunology. (Posted: March 4, 2002) |
| Risk of early febrile seizure with perinatal exposure to nucleoside analogues. Lancet. (Posted: February 21, 2002) |
| Condom use as a function of time in new and established adolescent sexual relationships. American Journal of Public Health. (Posted: February 21, 2002) |
| HIV infection in men who have sex with men. Sexually Transmitted Diseases. (Posted: February 19, 2002) |
| Correlates of nontransmission in US women at high risk of HIV-1 infection through sexual exposure. The Journal of Infectious Diseases. (Posted: February 19, 2002) |
| Immunization of rhesus monkeys with antigen-pulsed dendritic cells control SIV replication. AIDS Research and Human Retroviruses. (Posted: February 19, 2002) |
| Survival of AIDS according to injecting drug use among Puerto Rican AIDS patients. Cellular and Molecular Biology. (Posted: February 19, 2002) |
| NeuroAIDS: Developmental expression patterns of CCR5 and CXCR4 in the rhesus macaque brain. Journal of Neuroimmunology. (Posted: February 19, 2002) |
| Some recent results on HIV pathogenesis with implications for therapy and vaccines. Cellular and Molecular Biology. (Posted: February 19, 2002) |
| NeuroAIDS: Mononuclear phagocyte biophysiology influences brain transendothelial and tissue migration. Journal of Neuroimmunology. (Posted: February 19, 2002) |
| Unrecognized HIV infection among patients attending sexually transmitted disease clinics. American Journal of Public Health. (Posted: February 19, 2002) |
| Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of HIV-1-infected women. The Journal of Infectious Diseases. (Posted: February 19, 2002) |
| GAVI, the first steps: lessons for the Global Fund. Lancet. (Posted: February 19, 2002) |
| Safety and efficacy of an oral HIV vaccine (V-1 Immunitor). HIV Clinical Trials. (Posted: February 12, 2002) |
| Childhood sexual abuse and risk behaviors among high risk men. American Journal of Public Health. (Posted: February 11, 2002) |
| What Makes HIV-positive Gay Men Disclose Their Disease Status?. Lancet Infectious Diseases. (Posted: February 7, 2002) |
| Reducing heterosexual transmission of HIV in poor countries. British Medical Journal. (Posted: February 5, 2002) |
| What can we do to reduce mother to child transmission of HIV?. British Medical Journal. (Posted: February 5, 2002) |
| How can HIV be prevented in South Africa? A social perspective. British Medical Journal. (Posted: February 5, 2002) |
| The search for an HIV vaccine. British Medical Journal. (Posted: February 5, 2002) |
| First trial of the HIV-1 vaccine in Africa: Ugandan experience. British Medical Journal. (Posted: February 5, 2002) |
| Expression of vaccinia E3L and K3L genes by a novel recombinant canarypox HIV vaccine vector. Virology. (Posted: February 4, 2002) |
| Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men. AIDS Research and Human Retroviruses. (Posted: February 4, 2002) |
| Systemic and mucosal immune responses in mice with an HIV-DNA vaccine. Clinical Immunology. (Posted: February 4, 2002) |
| Incarceration and risk for HIV infection among injection drug users in Bangkok. Journal of Acquired Immune Deficiency Syndromes. (Posted: February 4, 2002) |
| Role of traditional birth attendants in preventing perinatal transmission of HIV. British Medical Journal. (Posted: January 31, 2002) |
| Progression to symptomatic disease in people infected with HIV-1. British Medical Journal. (Posted: January 30, 2002) |
| Socioeconomic status and use of crack/cocaine with unprotected anal sex. Journal of Acquired Immune Deficiency Syndromes. (Posted: January 29, 2002) |
| HIV-vaccine research takes one steps forward ... and one step back. Lancet. (Posted: January 28, 2002) |
| Anonymous reporting of HIV infection. European Journal of Epidemiology. (Posted: January 28, 2002) |
| Facing the reality of AIDS — a 15-year process?. Bulletin of the World Health Organization. (Posted: January 28, 2002) |
| International response to the HIV/AIDS epidemic: planning for success. Bulletin of the World Health Organization. (Posted: January 28, 2002) |
| Fighting HIV/AIDS: is success possible?. Bulletin of the World Health Organization. (Posted: January 28, 2002) |
| The effectiveness of HIV prevention and the epidemiological context. Bulletin of the World Health Organization. (Posted: January 28, 2002) |
| An HIV vaccine: how and when?. Bulletin of the World Health Organization. (Posted: January 28, 2002) |
| Prevention of mother-to-child transmission of HIV: challenges for the current decade. Bulletin of the World Health Organization. (Posted: January 28, 2002) |
| Factors in HIV/AIDS transmission in sub-Saharan Africa. Bulletin of the World Health Organization. (Posted: January 28, 2002) |
| Adoptive transfer of SIV naive autologous CD4(+) cells restores long-term nonprogressor status. Blood. (Posted: January 28, 2002) |
| NeuroAIDS: Cerebrospinal fluid viral load in HIV-1 positive hemophilic patients treated with HAART. Medicina (Buenos Aires). (Posted: January 28, 2002) |
| HIV distribution in subtypes and recombinant forms. Situation in Argentina. Medicina (Buenos Aires). (Posted: January 28, 2002) |
| Potent CD4(+) T cell responses elicited by a bicistronic HIV-1 DNA vaccine. Journal of Immunology. (Posted: January 28, 2002) |
| The past, present and future of HIV-vaccine development: a critical view. Drug Discovery Today. (Posted: January 28, 2002) |
| NeuroAIDS: Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology. (Posted: January 28, 2002) |
| Replication-incompetent adenoviral vaccine vector elicits effective anti-HIV immunity. Nature. (Posted: January 28, 2002) |
| Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature. (Posted: January 28, 2002) |
| NeuroAIDS: Substance P enhances HIV-1 replication in latently infected human immune cells. Journal of Neuroimmunology. (Posted: January 28, 2002) |
| Safety of blood supply for infectious diseases in Latin American countries, 1994-1997. Am. J. Trop. Med. Hyg. (Posted: January 28, 2002) |
| Immunogenicity and specificity of the candidate multi-epitope-vaccines against HIV-1. Immunopharmacology and Immunotoxicology. (Posted: January 28, 2002) |
| NeuroAIDS: Involvement of cyclin T1/cdk9 and Puralpha in the level of TNFalpha promoter activation by Tat. Journal of Neuroimmunology. (Posted: January 28, 2002) |
| Diversity of mosaic structures and common ancestry of HIV-1 BF intersubtype recombinant viruses. Journal of General Virology. (Posted: January 28, 2002) |
| NeuroAIDS: Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41. J. Neuropathol. Exp. Neurol. (Posted: January 28, 2002) |
| The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions. Journal of Infectious Diseases. (Posted: January 28, 2002) |
| Phase I clinical trial with HIV-1 gp160 plasmid vaccine in HIV-1-infected asymptomatic subjects. Eur. J. Clin. Microbiol. Infect. Dis. (Posted: January 28, 2002) |
| A DNA/MVA-based candidate HIV vaccine for Kenya induces multi-specific T cell responses. Journal of General Virology. (Posted: January 28, 2002) |
| A retroviral DNA vaccine vector. Viral Immunology. (Posted: January 28, 2002) |
| Influences on perceptions of sexual risk in a community sample of MSMs. Journal of Acquired Immune Deficiency Syndromes. (Posted: January 24, 2002) |
| HIV-2 does not protect against HIV-1 infection. AIDS. (Posted: January 23, 2002) |
| Risk of HIV infection in HSV-2-seropositive persons: a meta-analysis. Journal of Infectious Diseases. (Posted: January 17, 2002) |
| Cervicovaginal secretory antibodies to HIV-1 may protect highly exposed women. Journal of Infectious Diseases. (Posted: January 17, 2002) |
| The impact of peer education on the sexual health behaviour of homosexual men. Sexually Transmitted Infections. (Posted: January 17, 2002) |
| Repeat HIV testing, risk behaviors, and HIV seroconversion among young MSM. Journal of Acquired Immune Deficiency Syndromes. (Posted: January 17, 2002) |
| Cross-clade neutralizing antibody production by recombinant Mycobacterium bovis vaccine. Vaccine. (Posted: January 15, 2002) |
| The basis for HIV immunotherapeutic vaccines. Vaccine. (Posted: January 15, 2002) |
| Enhanced activation of rhesus T cells by vectors encoding a triad of costimulatory molecules. Vaccine. (Posted: January 15, 2002) |
| Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine. Vaccine. (Posted: January 15, 2002) |
| Enhanced CD8(+) immune response against a V3 loop multi-epitope polypeptide. Vaccine. (Posted: January 15, 2002) |
| Effect of an STD/HIV behavioral intervention on women's use of the female condom. American Journal of Public Health. (Posted: January 15, 2002) |
| Vaccine candidate consisting of neutralizing epitope and mutated epitopes. Immunobiology. (Posted: January 15, 2002) |
| NeuroAIDS: Progressive multifocal leukoencephalopathy in a child with hyperimmunoglobulin E. Neuropediatrics. (Posted: January 15, 2002) |
| NeuroAIDS: Aging and neuro-AIDS conditions. Journal of Clinical Epidemiology. (Posted: January 15, 2002) |
| NeuroAIDS: Neuropsychiatric aspects of HIV infection among older adults. Journal of Clinical Epidemiology. (Posted: January 15, 2002) |
| Epidemiological considerations in planning HIV preventive vaccine trials. AIDS. (Posted: January 15, 2002) |
| Protection of human subjects' rights in HIV-preventive clinical trials in Africa and Asia. AIDS. (Posted: January 15, 2002) |
| The epidemics of injecting drug use and HIV in Asia. AIDS. (Posted: January 15, 2002) |
| Vaccines and immunology - Recent advances in HIV/AIDS vaccine development. AIDS. (Posted: January 15, 2002) |
| New insights into protective humoral responses and HIV vaccines. AIDS. (Posted: January 15, 2002) |
| New insights into evaluating effective T-cell responses to HIV. AIDS. (Posted: January 15, 2002) |
| Innate immunity and HIV. AIDS. (Posted: January 15, 2002) |
| Novel vaccine delivery systems: solutions to HIV vaccine dilemmas?. AIDS. (Posted: January 15, 2002) |
| The HIV vaccine pipeline, from preclinical to phase III. AIDS. (Posted: January 15, 2002) |
| Differential selection of specific HIV-1/JC499 variants after inoculation of chimpanzees. Journal of Virology. (Posted: January 14, 2002) |
| NeuroAIDS: Visna virus-induced neuropathology. Journal of Virology. (Posted: January 14, 2002) |
| Cytokines as adjuvants for the induction of anti-HIV peptide IgG and IgA antibodies. Journal of Virology. (Posted: January 14, 2002) |
| A V3 mutation determines a global neutralization phenotype/CD4-independent infectivity. Journal of Virology. (Posted: January 14, 2002) |
| Chimpanzee models for human disease and immunobiology. Immunological Reviews. (Posted: January 14, 2002) |
| Determining the immune mechanisms of protection from AIDS. Immunological Reviews. (Posted: January 14, 2002) |
| Virus replication and evolution drive the kinetics and specificity of SIV-specific CTLs. Immunological Reviews. (Posted: January 14, 2002) |
| Understanding cytotoxic T-lymphocyte escape during simian immunodeficiency virus infection. Immunological Reviews. (Posted: January 14, 2002) |
| Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development. Immunological Reviews. (Posted: January 14, 2002) |
| Immune evasion strategies of the primate lentiviruses. Immunological Reviews. (Posted: January 14, 2002) |
| Native HIV-1 Tat protein targets monocyte-derived dendritic cells. Journal of Immunology. (Posted: January 14, 2002) |
| Vaccine protection against functional CTL abnormalities in SHIV-infected rhesus monkeys. Journal of Immunology. (Posted: January 14, 2002) |
| An HIV-1 ubiquitin expression library immunization vaccine. Journal of Immunology. (Posted: January 14, 2002) |
| HIV counseling and testing of pregnant women in sub-Saharan Africa. Journal of Acquired Immune Deficiency Syndromes. (Posted: January 14, 2002) |
| Population-based HIV testing and counseling in rural Uganda. Journal of Acquired Immune Deficiency Syndromes. (Posted: January 14, 2002) |
| Can HIV-1-contaminated syringes be disinfected?. Journal of Acquired Immune Deficiency Syndromes. (Posted: January 14, 2002) |
| NeuroAIDS: Changes in monocyte/macrophage neurotoxicity in the era of HAART. AIDS. (Posted: January 14, 2002) |
| NeuroAIDS: Tat reduces the glutamate-induced intracellular Ca2+ increase in cultured cortical astrocytes. European Journal of Neuroscience. (Posted: January 14, 2002) |
| Vitamin A supplements ameliorate the adverse effect of HIV-1. Pediatrics. (Posted: January 14, 2002) |
| Effect of an STD/HIV behavioral intervention on women's use of the female condom. American Journal of Public Health. (Posted: January 10, 2002) |
|
More Journal articles: This month | Search archive |
 |
